InnoCare Pharma Ltd. (INCPF) Financial Statements
InnoCare Pharma Ltd. Financial Overview
InnoCare Pharma Ltd.'s market cap is currently $2.14B. The company's EPS TTM is $0.77; its P/E ratio is 12.39; InnoCare Pharma Ltd. is estimated to report earnings on April 1, 2027, and the estimated EPS forecast is $0.04. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 2.30B | $ 1.01B | $ 738.54M | $ 625.40M | $ 1.04B |
| Gross Profit | $ 2.01B | $ 871.01M | $ 610.10M | $ 482.01M | $ 977.37M |
| Operating Income | $ 440.59M | $ -525.78M | $ -651.15M | $ -770.40M | $ -193.87M |
| EBITDA | $ 555.89M | $ -442.92M | $ -516.55M | $ -808.28M | $ 16.23M |
| Net Income | $ 625.84M | $ -440.63M | $ -631.26M | $ -886.59M | $ -64.55M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 7.34B | $ 6.22B | $ 8.22B | $ 9.01B | $ 6.25B |
| Total Assets | $ 10.83B | $ 9.41B | $ 9.92B | $ 10.32B | $ 7.40B |
| Total Debt | $ 1.61B | $ 1.27B | $ 1.35B | $ 1.54B | $ 1.27B |
| Net Debt | $ -5.46B | $ -4.95B | $ -6.88B | $ -7.16B | $ -4.66B |
| Total Liabilities | $ 3.07B | $ 2.66B | $ 2.74B | $ 2.68B | $ 1.74B |
| Stockholders' Equity | $ 7.73B | $ 6.73B | $ 7.15B | $ 7.60B | $ 5.60B |
| Cash Flow | |||||
| Free Cash Flow | $ 130.80M | $ -443.78M | $ -926.00M | $ -935.88M | $ -11.00K |
| Operating Cash Flow | $ 199.15M | $ -365.55M | $ -671.34M | $ -565.55M | $ 167.06M |
| Investing Cash Flow | $ -358.03M | $ 1.11B | $ 666.91M | $ -1.73B | $ -1.73B |
| Financing Cash Flow | $ -32.84M | $ -285.60M | $ 1.31M | $ 3.09B | $ 2.54B |
Currency in CNY
